Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - Thomson StreetEvents

Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - Thomson StreetEvents
Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Published Jan 13, 2025
12 pages (8224 words) — Published Jan 13, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RXRX.OQ presentation 13-Jan-25 3:30pm GMT

  
Brief Excerpt:

...Good morning. Happy New year, and welcome to the 43rd Annual JP Morgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. And it's my pleasure to introduce one of our first presenting companies this morning Recursion, and presenting on behalf of the company is CEO, Chris Gibson. Before I give him the podium, (Event Instructions) So with that, Chris, thanks for joining us. Chris Gibson ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Recursion Pharmaceuticals Inc
Ticker
RXRX.OQ
Time
3:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Eric Joseph - JPMorgan Chase & Co. - Analyst : Okay, great. Well, thanks Chris. And again for those who have questions, just raise your hand, we'll get a mic over to you. But maybe just to start off Chris just picking up from the business combination that you highlighted. If we're right now, we're kind of as we look at your present pipeline. It's sort of a marriage of the two former separate entities. I guess how do we think -- how should we be thinking about sort of the synergies that the combination with Exscientia sort of bring to the table and sort of where would they possibly be reflected in either your existing or growing expanding pipeline?

Question: Eric Joseph - JPMorgan Chase & Co. - Analyst : Thank you. For your virtual cell model, which seems pretty exciting, you mentioned for the protein side that you were either partnering already or were in the process of partnering. Can you announce who you're partnering with or not yet?

Question: Eric Joseph - JPMorgan Chase & Co. - Analyst : And (inaudible - microphone inaccessible) Unidentified Participant May I know the difficulty in building virtual sales?

Question: Eric Joseph - JPMorgan Chase & Co. - Analyst : Maybe just picking up on the virtual sub model. I mean, there are different cell types, right? So maybe just talk a little bit sort of the dynamicism that might maybe going into the model. Can you shift it to kind of reflect different cell phenotype cell types?

Question: Eric Joseph - JPMorgan Chase & Co. - Analyst : And just as it relates to the partnering initiatives on this particular front, are there certain I guess to what extent -- just how to think about sort of the scope of treatment areas that are in play? Are there any areas that we'd want to retain or kind of off limits for the purposes of building out your own pipeline or are you kind of agnostic? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 13, 2025 / 3:30PM, RXRX.OQ - Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference

Table Of Contents

Recursion Pharmaceuticals Inc Q2 2025 Earnings Call Transcript – 2025-08-05 – US$ 54.00 – Edited Transcript of RXRX.OQ earnings conference call or presentation 5-Aug-25 12:00pm GMT

Recursion Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2025-06-18 – US$ 54.00 – Edited Transcript of RXRX.OQ shareholder or annual meeting 18-Jun-25 6:00pm GMT

Recursion Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 10-Jun-25 7:20pm GMT

Recursion Pharmaceuticals Inc Q1 2025 Earnings Call Transcript – 2025-05-05 – US$ 54.00 – Edited Transcript of RXRX.OQ earnings conference call or presentation 5-May-25 12:00pm GMT

Recursion Pharmaceuticals Inc Q4 2024 Earnings Call Transcript – 2025-02-28 – US$ 54.00 – Edited Transcript of RXRX.OQ earnings conference call or presentation 28-Feb-25 1:30pm GMT

Recursion Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of RXRX.OQ shareholder or annual meeting 12-Nov-24 10:00pm GMT

Recursion Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2024-06-03 – US$ 54.00 – Edited Transcript of RXRX.OQ shareholder or annual meeting 3-Jun-24 2:00pm GMT

Recursion Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 14-Nov-23 10:59am GMT

Recursion Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript – 2023-09-26 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 26-Sep-23 3:05pm GMT

Recursion Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2023-06-16 – US$ 54.00 – Edited Transcript of RXRX.OQ shareholder or annual meeting 16-Jun-23 6:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript" Jan 13, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Recursion-Pharmaceuticals-Inc-at-JPMorgan-Healthcare-Conference-T16220505>
  
APA:
Thomson StreetEvents. (2025). Recursion Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript Jan 13, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Recursion-Pharmaceuticals-Inc-at-JPMorgan-Healthcare-Conference-T16220505>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.